Literature DB >> 12717210

A schema for histologic grading of small intestine allograft acute rejection.

Tong Wu1, Kareem Abu-Elmagd, Geoffy Bond, Michael A Nalesnik, Parmjeet Randhawa, A Jake Demetris.   

Abstract

BACKGROUND: Histologic evaluation of small bowel allograft biopsies is important for the diagnosis of acute rejection. However, a standard histologic schema to grade the severity of intestinal acute rejection is not currently available. The primary goal of this study was to develop a histologic grading system for the diagnosis of small bowel allograft acute rejection.
METHODS: We evaluated 3268 small bowel allograft biopsies obtained from adult patients who underwent small bowel transplantation at the University of Pittsburgh Medical Center between 1990 and 1999. A histologic grading system was proposed and validated by retrospective correlation with clinical outcomes.
RESULTS: Among the 3268 biopsies, 180 acute rejection episodes were diagnosed (88 indeterminate, 74 mild, 14 moderate, and 4 severe). All four histologically diagnosed, severe acute rejection episodes resulted in graft failure before resolution, despite aggressive immunosuppressive therapy. Four of the 14 moderate acute rejection episodes were associated with unfavorable clinical outcomes. In contrast, the 74 mild and 88 indeterminate acute rejection episodes were not associated with unfavorable clinical outcomes. Statistical analysis for trend revealed that grades indicating more severe acute rejection episodes were associated with a greater probability of unfavorable outcomes (P<0.01). In addition, there was good overall agreement among different pathologists regarding the diagnosis of acute rejection using the proposed schema, suggesting that this system is practical.
CONCLUSIONS: This study provides a reliable predictive schema for assessment of the severity of human small bowel acute rejection.

Entities:  

Mesh:

Year:  2003        PMID: 12717210     DOI: 10.1097/01.TP.0000062840.49159.2F

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  29 in total

1.  Calprotectin: a novel noninvasive marker for intestinal allograft monitoring.

Authors:  Debra Sudan; Luciano Vargas; Yimin Sun; Lisette Bok; Gerard Dijkstra; Alan Langnas
Journal:  Ann Surg       Date:  2007-08       Impact factor: 12.969

Review 2.  Where are we at with short bowel syndrome and small bowel transplant.

Authors:  Baris Dogu Yildiz
Journal:  World J Transplant       Date:  2012-12-24

3.  Long-term survival in visceral transplant recipients in the new era: A single-center experience.

Authors:  Ahmed M Elsabbagh; Jason Hawksworth; Khalid M Khan; Stuart S Kaufman; Nada A Yazigi; Alexander Kroemer; Coleman Smith; Thomas M Fishbein; Cal S Matsumoto
Journal:  Am J Transplant       Date:  2019-03-26       Impact factor: 8.086

Review 4.  India's first successful intestinal transplant: the road traveled and the lessons learnt.

Authors:  A S Soin; R Mohanka; N Saraf; A Rastogi; S Goja; B Menon; V Vohra; S Saigal; R Sud; D Kumar; P Bhangui; S Ramachandra; P Singla; G Shetty; K Raghvendra; Kareem M Abu Elmagd
Journal:  Indian J Gastroenterol       Date:  2014-02-07

Review 5.  Advances in small bowel transplantation.

Authors:  Alp Gürkan
Journal:  Turk J Surg       Date:  2017-09-01

6.  Increased expression of peripheral blood leukocyte genes implicate CD14+ tissue macrophages in cellular intestine allograft rejection.

Authors:  Chethan Ashokkumar; Mylarappa Ningappa; Sarangarajan Ranganathan; Brandon W Higgs; Qing Sun; Lori Schmitt; Sara Snyder; Jennifer Dobberstein; Maria Branca; Ronald Jaffe; Adriana Zeevi; Robert Squires; Feras Alissa; Benjamin Shneider; Kyle Soltys; Geoffrey Bond; Kareem Abu-Elmagd; Abhinav Humar; George Mazariegos; Hakon Hakonarson; Rakesh Sindhi
Journal:  Am J Pathol       Date:  2011-08-18       Impact factor: 4.307

7.  Myeloid-derived suppressor cells increase and inhibit donor-reactive T cell responses to graft intestinal epithelium in intestinal transplant patients.

Authors:  Shinji Okano; Kareem Abu-Elmagd; Danielle D Kish; Karen Keslar; William M Baldwin; Robert L Fairchild; Masato Fujiki; Ajai Khanna; Mohammed Osman; Guilherme Costa; John Fung; Charles Miller; Hiroto Kayashima; Koji Hashimoto
Journal:  Am J Transplant       Date:  2018-04-17       Impact factor: 8.086

8.  MiR-200b in heme oxygenase-1-modified bone marrow mesenchymal stem cell-derived exosomes alleviates inflammatory injury of intestinal epithelial cells by targeting high mobility group box 3.

Authors:  Dong Sun; Huan Cao; Liu Yang; Ling Lin; Bin Hou; Weiping Zheng; Zhongyang Shen; Hongli Song
Journal:  Cell Death Dis       Date:  2020-06-25       Impact factor: 8.469

9.  Interleukin-17 plays a critical role in the acute rejection of intestinal transplantation.

Authors:  Jian-Jun Yang; Fan Feng; Liu Hong; Li Sun; Meng-Bin Li; Ran Zhuang; Feng Pan; Ying-Mei Wang; Wei-Zhong Wang; Guo-Sheng Wu; Hong-Wei Zhang
Journal:  World J Gastroenterol       Date:  2013-02-07       Impact factor: 5.742

10.  Incidence of bloodstream infections in small bowel transplant recipients receiving selective decontamination of the digestive tract: A single-center experience.

Authors:  David Galloway; Lara Danziger-Isakov; Monique Goldschmidt; Trina Hemmelgarn; Joshua Courter; Jaimie D Nathan; Maria Alonso; Greg Tiao; Lin Fei; Samuel Kocoshis
Journal:  Pediatr Transplant       Date:  2015-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.